Keshun Waterproof Technology Co.,Ltd. (300737.SZ)
Foshan, CN
Keshun Waterproof Technology Co.,Ltd. specializes in delivering comprehensive waterproofing solutions for a wide range of building projects. Their extensive product line includes essential waterproofing components such as coiled membranes and liquid coatings, alongside specialized offerings like mortar paints, various sealing agents, and construction auxiliary materials. The company also supplies metal roofing systems and provides services for tile paving and leak repair, ensuring structural integrity. Founded in 1996, Keshun also extends its expertise to offer building repair solutions and is based in Foshan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.41% | -4.10% | +6.61% | -3.20% | +39.62% | +32.00% | +42.63% | -23.98% | -64.72% | -8.79% | -8.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-11.5% Q1'26: +4.3% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-1,330.8% Q1'26: +66.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-12.8% Q1'26: -6.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-8.2% Q1'26: +7.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%-9.2% Q1'26: +5.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-1.2% ★ Q1'26: -5.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-18.67× Q1'26: 10.40× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.10B
est: 2.92B (+6.1%)
|
4.65B
est: 4.64B (+0.3%)
|
6.24B
est: 6.29B (-0.8%)
|
7.80B
est.
|
7.77B
est: 8.00B (-2.9%)
|
7.94B
est: 7.08B (+12.2%)
|
7.66B
est: 7.08B (+8.2%)
|
6.83B
est: 6.74B (+1.3%)
|
6.04B
est: 6.37B (-5.1%)
|
6.67B
6.66B – 6.68B
+4.7% YoY
|
7.29B
7.27B – 7.31B
+9.4% YoY
|
7.95B
7.94B – 7.95B
+9.0% YoY
|
| EBITDA |
299.85M
est: 262.34M (+14.3%)
|
533.23M
est: 416.53M (+28.0%)
|
1.18B
est: 564.82M (+109.0%)
|
700.61M
est.
|
1.04B
est: 718.76M (+44.2%)
|
-43.09M
est: 312.88M (-113.8%)
|
503.76M
est: 312.88M (+61.0%)
|
425.80M
est: 298.04M (+42.9%)
|
-211.83M
est: 281.38M (-175.3%)
|
294.71M
294.34M – 295.07M
+4.7% YoY
|
322.29M
321.53M – 323.06M
+9.4% YoY
|
351.28M
350.98M – 351.58M
+9.0% YoY
|
| EBIT |
258.77M
est: 181.27M (+42.8%)
|
468.37M
est: 287.81M (+62.7%)
|
1.08B
est: 390.27M (+177.2%)
|
484.10M
est.
|
882.94M
est: 496.64M (+77.8%)
|
-301.83M
est: 81.80M (-469.0%)
|
301.80M
est: 81.80M (+268.9%)
|
165.62M
est: 77.92M (+112.5%)
|
-492.59M
est: 73.57M (-769.6%)
|
77.05M
76.96M – 77.15M
+4.7% YoY
|
84.27M
84.06M – 84.47M
+9.4% YoY
|
91.84M
91.77M – 91.92M
+9.0% YoY
|
| Net Income |
185.27M
est: 275.44M (-32.7%)
|
363.36M
est: 362.67M (+0.2%)
|
890.33M
est: 836.63M (+6.4%)
|
898.09M
est.
|
672.62M
est: 321.35M (+109.3%)
|
-337.60M
est: -300.38M (-12.4%)
|
178.25M
est: -300.38M (+159.3%)
|
44.07M
est: 211.91M (-79.2%)
|
-535.34M
est: 66.92M (-900.0%)
|
321.21M
320.69M – 321.72M
+380.0% YoY
|
434.94M
339.74M – 543.57M
+35.4% YoY
|
597.80M
596.84M – 598.76M
+37.4% YoY
|
| SGA |
539.46M
est: 190.48M (+183.2%)
|
766.08M
est: 302.44M (+153.3%)
|
618.42M
est: 410.11M (+50.8%)
|
508.70M
est.
|
753.37M
est: 521.88M (+44.4%)
|
904.52M
est: 716.40M (+26.3%)
|
800.54M
est: 716.40M (+11.7%)
|
969.78M
est: 682.42M (+42.1%)
|
294.35M
est: 644.27M (-54.3%)
|
674.79M
673.96M – 675.63M
+4.7% YoY
|
737.96M
736.20M – 739.72M
+9.4% YoY
|
804.33M
803.64M – 805.02M
+9.0% YoY
|
| EPS |
0.17
est: 0.25 (-32.0%)
|
0.33
est: 0.33 (+0.3%)
|
0.82
est: 0.76 (+8.0%)
|
0.82
est.
|
0.60
est: 0.29 (+105.7%)
|
-0.29
est: -0.27 (-7.7%)
|
0.15
est: -0.27 (+155.7%)
|
0.04
est: 0.19 (-79.5%)
|
-0.48
est: 0.06 (-900.0%)
|
0.29
0.29 – 0.29
+380.0% YoY
|
0.40
0.30 – 0.49
+37.5% YoY
|
0.54
0.54 – 0.54
+35.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 51.9K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 136.4K | 0.39% |
| 3 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.00% | 5.3K | 0.49% |
| 4 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 198.1K | 0.07% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 83.9K | 0.29% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 22.9K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 10.2K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.13M | 0.06% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 49.4K | 0.28% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 42.4K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dongqing Chen | Vice President | — | female |
| Ji Ye | Vice President | — | male |
| Shan Liu | Vice President | — | male |
| Shuangxi Bi | Vice President & Director | — | male |
| Song Lu | Vice President, Chief Financial Officer & Non-Independent Director | — | male |
| Wei Xing Xu | Accounting Supervisor | — | — |
| Weizhong Chen | Founder & Non-Independent Chairman | — | male |
| Xianjun Wang | Vice President | — | male |
| Yong Fang | President, MD & Non-Independent Director | — | male |
| Zhengzhi Duan | Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300737.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
